Clinical features, cardiovascular risk profile, and therapeutic trajectories of patients with type 2 diabetes candidate for oral semaglutide therapy in the Italian specialist care
Prof. Gian Paolo Fadini, MD PhD
Dipartimento di Medicina, Università di Padova